| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 12.1 | 12.8 | 11.2 |
| Other income | 0.0 | 0.1 | 0.0 |
| Total income | 12.1 | 12.9 | 11.2 |
| Profit before exceptional items & tax | 0.6 | 1.1 | 0.6 |
| Profit before tax | 0.6 | 1.1 | 0.6 |
| Net profit | 0.6 | 1.0 | 0.4 |
| Operating margin | 5.0% | 8.5% | 5.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +50.00% |
|---|---|
| Net profit, quarter on quarter | -40.00% |
| Revenue, year on year | +8.00% |
| Operating profit, quarter on quarter | -40.00% |
BSE results filing, NSE: CHOKSILA. Figures extracted from the filing.
Choksi Laboratories Ltd: key numbers
- Share price
- ₹192.45
- Market cap
- ₹134.1 Cr
- Revenue (annual)
- ₹46.01 Cr
- Net profit (annual)
- ₹1.96 Cr
- P/E (TTM)
- 62.0×Sector 53.1×
- Promoter holding
- 31.48%+0.00% QoQ
- FII holding
- 10.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Choksi Laboratories Ltd
All →Choksi Laboratories Annual General Meeting
Choksi Laboratories Ltd has scheduled an EGM for October 17, 2026, to seek shareholder approval for issuing 3.50 lakh convertible warrants at ₹177 per warrant.
- Value
- ₹6.20 Cr
Choksi Laboratories Capital Structure Change
Choksi Laboratories board approved a preferential issue of 3.5 lakh warrants to promoters at Rs 177 per warrant, totaling Rs 6.195 Crore.
- Value
- ₹6.20 Cr
Choksi Laboratories Annual General Meeting
Choksi Laboratories filed proceedings of its 33rd AGM held on 18 September 2026. Directors Sunil Choksi and Himika Choksi were re-appointed as Whole-Time Directors.
Choksi Laboratories Board Meeting Date
Choksi Laboratories announced a Board meeting on September 19, 2026, to discuss a proposal for raising funds through equity or convertible securities.
Choksi Laboratories Other Announcement
Choksi Laboratories Limited has dispatched letters to shareholders with unregistered email addresses. The communication provides access details for the FY 2025-26 Annual Report and AGM notice.
Choksi Laboratories Annual Report
Choksi Laboratories has submitted its 33rd Annual Report for the financial year 2025-26. The report and the notice of the upcoming AGM are now available.